Post-Transplant Diabetes Mellitus

New Orleans, LA US
December 3, 2019
This activity will provide an engaging manner of educating those who play a significant role in caring for this specific patient population. Due to a large population of our patients being either pre-transplant or post-transplant patients, this education will also give more insight on how they should be managed throughout their course of therapy. Despite this specific area of education, this education will help a wide variety of our patients at Ochsner Medical Center. Most of our patients have diabetes, are immunocompromised and have received a transplant or will within the near future.  This activity will provide an engaging manner of educating those who play a significant role in caring for this specific patient population. Due to a large population of our patients being either pre-transplant or post-transplant patients, this education will also give more insight on how they should be managed throughout their course of therapy. Despite this specific area of education, this education will help a wide variety of our patients at Ochsner Medical Center. Most of our patients have diabetes, are immunocompromised and have received a transplant or will within the near future. 

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Define the differences between post-transplant diabetes mellitus and new onset diabetes after transplant
  2. Discuss the pathophysiology post-transplant diabetes mellitus
  3. Outline current evidence supporting use of anti-glycemic agents for post-transplant diabetes mellitus
  4. Apply treatment options in post-transplant diabetes mellitus

Pharmacy technician learning objectives

  1. Define the differences between post-transplant diabetes mellitus and new onset diabetes after transplant
  2. Recognize brand and generic names of pharmacological options for the treatment of diabetes post-transplant
  3. Identify drug classes that can be used in post-transplant diabetes mellitus
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
12/03/2019
Course expires: 
01/16/2020
Event starts: 
12/03/2019 - 12:30pm
Event ends: 
12/03/2019 - 1:30pm
Cost:
$0.00
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA 70121
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
Planning committee members
Ushma Kaszubski, PharmD, BCPS
Pharmacist
Ochsner Medical Center
 
Bailey Wise, PharmD, BCPS
Pharmacist
Ochsner Medical Center
 
 
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLE
Clinical Pharmacy Director
Vizient
 
 
Presenter
Shima Shafiyan, PharmD
Pharmacist – PGY-1 Resident
Ochsner Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-201-L01-P
Universal Activity Number: JA0006103-9999-19-201-L01-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.